Why the study?
With no approved vaccines or treatments for rhinovirus, researchers investigated whether stabilizing genomic RNA secondary structures, such as G-quadruplexes, could inhibit the viral replication cycle.
Population
Synthetic RNA oligonucleotides derived from the RV-A2 genome and viral RNA cores
Comparison
GQ-stabilizing compounds (pyridostatin and PhenDC3) in Na+ vs K+-containing phosphate buffers
Design
Preclinical in vitro and in vivo laboratory study
Authors
Loading...
Pyridostatin may inhibit rhinovirus uncoating; leaves open whether G-quadruplex stabilization represents a viable antiviral approach.
Stabilizing G-quadruplexes in the rhinovirus genome with small molecules inhibits viral uncoating in a sodium-dependent manner, presenting a potential antiviral strategy.
Real-Hohn et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: